Correlation of MR Imaging and MR Spectroscopy Findings with Cognitive Impairment in Mucopolysaccharidosis II

Overview

Journal AJNR Am J Neuroradiol

Specialty Neurology

Date 2007 Jun 16

PMID 17569950

Citations 24

Authors

L Vedolin

I V D Schwartz

M Komlos

A Schuch

A C Puga

L L C Pinto

A P Pires

R Giugliani

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: There are no reliable markers to predict neurologic outcome of patients with mucopolysaccharidosis (MPS) II. We hypothesized that brain MR imaging and MR spectroscopy are useful in depicting features related to cognitive impairment (CI) in MPS II.

Materials And Methods: Nineteen male patients with MPS II were included in this study. They were evaluated through intelligence/developmental tests to be classified in 2 groups: patients with CI (group A) or patients without CI (group B). Brain MR imaging evaluated white matter (WM) lesions, hydrocephalus, and brain atrophy. Voxels from MR spectroscopy (point-resolved spectroscopy TE 30 ms) were positioned in the WM of the deep right frontal lobe and at the gray matter (GM) in the posterior occipital cortex across the midline. Comparison of MR imaging and MR spectroscopy findings between these 2 groups and a control group was performed.

Results: The mean age of the patients was 9.6 years (group A, 7.08 years old, 12 patients; group B, 14 years old, 7 patients; P = .076). Brain atrophy and hydrocephalus were more frequently found in group A patients (P=.006 and P=.029, respectively); these patients also presented more severe WM lesions than patients from group B (P=.022). Patients from group A also had a higher myo-inositol (mIns)/creatine (Cr) ratio in the GM (P=.046) and in the WM (P=.032). The choline/Cr and N-acetylaspartate/Cr ratios were similar in both groups.

Conclusions: Our study showed that severe WM lesions, brain atrophy, hydrocephalus, and elevated mIns/Cr were more common in patients with MPS II and with CI.

Citing Articles

Atypical Neuroimaging Findings in a Patient With Mucopolysaccharidosis Type VII (Sly Syndrome).

Lamghare P, Agarwal U, Kalekar T, Krishnani K Cureus. 2024; 16(8):e66819.

PMID: 39280482 PMC: 11393383. DOI: 10.7759/cureus.66819.

Venous Sinus Stenosis with Prominent Emissary Veins: A New Common Cranial MRI Finding of Mucopolysaccharidosis I.

Huang S, Gupta A, Orchard P, Lund T, Nascene D AJNR Am J Neuroradiol. 2023; 44(10):1236-1239.

PMID: 37679022 PMC: 10549949. DOI: 10.3174/ajnr.A7997.

Magnetic resonance imaging findings of the posterior fossa in 47 patients with mucopolysaccharidoses: A cross-sectional analysis.

Reichert R, Perez J, Dalla-Corte A, Pinto E Vairo F, de Souza C, Giugliani R JIMD Rep. 2021; 60(1):32-41.

PMID: 34258139 PMC: 8260483. DOI: 10.1002/jmd2.12212.

Can serial cerebral MRIs predict the neuronopathic phenotype of MPS II?.

Vollebregt A, Ebbink B, Rizopoulos D, Lequin M, Aarsen F, Shapiro E J Inherit Metab Dis. 2020; 44(3):751-762.

PMID: 33330992 PMC: 8248480. DOI: 10.1002/jimd.12342.

Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses.

Barone R, Pellico A, Pittala A, Gasperini S Ital J Pediatr. 2018; 44(Suppl 2):121.

PMID: 30442188 PMC: 6238256. DOI: 10.1186/s13052-018-0561-2.

References

Kim J, Lentz M, Westmoreland S, Greco J, Ratai E, Halpern E . Relationships between astrogliosis and 1H MR spectroscopic measures of brain choline/creatine and myo-inositol/creatine in a primate model. AJNR Am J Neuroradiol. 2005; 26(4):752-9. PMC: 7977133. View

Robertson S, Klug G, Rogers J . Cerebrospinal fluid shunts in the management of behavioural problems in Sanfilippo syndrome (MPS III). Eur J Pediatr. 1998; 157(8):653-5. DOI: 10.1007/s004310050904. View

Barone R, Parano E, Trifiletti R, Fiumara A, Pavone P . White matter changes mimicking a leukodystrophy in a patient with Mucopolysaccharidosis: characterization by MRI. J Neurol Sci. 2002; 195(2):171-5. DOI: 10.1016/s0022-510x(02)00014-x. View

Walkley S . Cellular pathology of lysosomal storage disorders. Brain Pathol. 1998; 8(1):175-93. PMC: 8098147. DOI: 10.1111/j.1750-3639.1998.tb00144.x. View

Katz-Brull R, Lenkinski R, Du Pasquier R, Koralnik I . Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy. Neurology. 2004; 63(5):897-900. DOI: 10.1212/01.wnl.0000137420.58346.9f. View

Castillo M, Kwock L, Mukherji S . Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol. 1996; 17(1):1-15. PMC: 8337957. View

Takahashi Y, Sukegawa K, Aoki M, Ito A, Suzuki K, Sakaguchi H . Evaluation of accumulated mucopolysaccharides in the brain of patients with mucopolysaccharidoses by (1)H-magnetic resonance spectroscopy before and after bone marrow transplantation. Pediatr Res. 2001; 49(3):349-55. DOI: 10.1203/00006450-200103000-00008. View

Muenzer J, Wraith J, Beck M, Giugliani R, Harmatz P, Eng C . A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet Med. 2006; 8(8):465-73. DOI: 10.1097/01.gim.0000232477.37660.fb. View

Inglese M, Nusbaum A, Pastores G, Gianutsos J, Kolodny E, Gonen O . MR imaging and proton spectroscopy of neuronal injury in late-onset GM2 gangliosidosis. AJNR Am J Neuroradiol. 2005; 26(8):2037-42. PMC: 8148816. View

10.

KURU Y, Sumie H, Ito T, Hattori N, Okuma Y, Mizuno Y . MRI findings in the mild type of mucopolysaccharidosis II (Hunter's syndrome). Neuroradiology. 1990; 32(4):328-30. DOI: 10.1007/BF00593056. View

11.

Hochuli M, Wuthrich K, Steinmann B . Two-dimensional NMR spectroscopy of urinary glycosaminoglycans from patients with different mucopolysaccharidoses. NMR Biomed. 2003; 16(4):224-36. DOI: 10.1002/nbm.833. View

12.

Mancini G, van Diggelen O, Huijmans J, Stroink H, de Coo R . Pitfalls in the diagnosis of multiple sulfatase deficiency. Neuropediatrics. 2001; 32(1):38-40. DOI: 10.1055/s-2001-12213. View

13.

Meikle P, Hopwood J, Clague A, Carey W . Prevalence of lysosomal storage disorders. JAMA. 1999; 281(3):249-54. DOI: 10.1001/jama.281.3.249. View

14.

Vougioukas V, Berlis A, Kopp M, Korinthenberg R, Spreer J, Van Velthoven V . Neurosurgical interventions in children with Maroteaux-Lamy syndrome. Case report and review of the literature. Pediatr Neurosurg. 2001; 35(1):35-8. DOI: 10.1159/000050383. View

15.

Mucke L, Oldstone M, Morris J, Nerenberg M . Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury. New Biol. 1991; 3(5):465-74. View

16.

Ben-Zeev B, Gross V, Kushnir T, Shalev R, Hoffman C, Shinar Y . Vacuolating megalencephalic leukoencephalopathy in 12 Israeli patients. J Child Neurol. 2001; 16(2):93-9. DOI: 10.1177/088307380101600205. View

17.

Ashwal S, Holshouser B, Tong K, Serna T, Osterdock R, Gross M . Proton spectroscopy detected myoinositol in children with traumatic brain injury. Pediatr Res. 2004; 56(4):630-8. DOI: 10.1203/01.PDR.0000139928.60530.7D. View

18.

Parsons V, Hughes D, Wraith J . Magnetic resonance imaging of the brain, neck and cervical spine in mild Hunter's syndrome (mucopolysaccharidoses type II). Clin Radiol. 1996; 51(10):719-23. DOI: 10.1016/s0009-9260(96)80246-7. View

19.

Seto T, Kono K, Morimoto K, Inoue Y, Shintaku H, Hattori H . Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation. Ann Neurol. 2001; 50(1):79-92. DOI: 10.1002/ana.1098. View

20.

Yamasue H, Fukui T, Fukuda R, Yamada H, Yamasaki S, Kuroki N . 1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia. Neuroreport. 2002; 13(16):2133-7. DOI: 10.1097/00001756-200211150-00029. View